Literature DB >> 22887473

Normative growth charts for individuals with Costello syndrome.

Mary R Sammon1, Dan Doyle, Elizabeth Hopkins, Katia Sol-Church, Deborah L Stabley, John McGready, Kerry Schulze, Yewande Alade, Julie Hoover-Fong, Karen W Gripp.   

Abstract

Costello syndrome is a rare condition due to heterozygous germline mutations in the proto-oncogene HRAS. It affects multiple organ systems and includes severe failure-to-thrive, short stature, and macrocephaly. The goal of this study was to develop Costello syndrome-specific growth curves. We collected height, weight, and head circumference (OFC) measurements from 94 individuals (45 males and 49 females). Their HRAS mutation spectrum reflects previously published cohorts, with p.G12S in 77.7%. Participants received medical care, therefore our data does not reflect natural history per se, but rather growth with nutritional support. Due to limited cohort size, we analyzed data from males and females together. Weight-for-age data included 417 separate measurements from 80 individuals age 0-36 months, and 585 measurements from 82 individuals for age 0-10 years. Height-for-age data were derived from 391 measurements from 77 individuals age 0-36 months, and 591 measurements from 90 individuals age 0-10 years. Measurements obtained after growth hormone exposure in 15 individuals were excluded in this analysis. The OFC curve was derived from 221 measurements from 55 individuals age 0-36 months. Centiles (5th, 50th, and 95th) were estimated across the age continuum for each growth parameter, and compared to gender-specific curves for average stature individuals. The resulting curves demonstrate very slow weight gain in the first 2 years. Short stature is seen in many, but after age 4 years the 95th centile for height falls within the low normal range for average stature children. Head circumference curves largely overlap those for average stature, reflecting relative macrocephaly.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22887473     DOI: 10.1002/ajmg.a.35534

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

2.  Early-lethal Costello syndrome due to rare HRAS Tandem Base substitution (c.35_36GC>AA; p.G12E)-associated pulmonary vascular disease.

Authors:  K Nicole Weaver; Dehua Wang; James Cnota; Nicholas Gardner; Deborah Stabley; Katia Sol-Church; Karen W Gripp; David P Witte; Kevin E Bove; Robert J Hopkin
Journal:  Pediatr Dev Pathol       Date:  2014-08-18

3.  Rapid Weight Loss and Severe Failure to Thrive Mimicking Lipodystrophy Syndrome in a 1-Year-Old Taiwanese Girl with Costello Syndrome.

Authors:  Yu-Min Syu; Hung-Chang Lee; Jui-Hsing Chang; Chung-Lin Lee; Chih-Kuang Chuang; Huei-Ching Chiu; Ya-Hui Chang; Hsiang-Yu Lin; Shuan-Pei Lin
Journal:  Children (Basel)       Date:  2022-06-16

Review 4.  Multidisciplinary Management of Costello Syndrome: Current Perspectives.

Authors:  Chiara Leoni; Germana Viscogliosi; Marco Tartaglia; Yoko Aoki; Giuseppe Zampino
Journal:  J Multidiscip Healthc       Date:  2022-06-02

5.  Precocious puberty and Chiari I malformation with syrinx: a case report of an unusual presentation of Costello syndrome.

Authors:  Naomi S Schwartz; Molly O Regelmann
Journal:  Int J Pediatr Endocrinol       Date:  2019-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.